|
|
Blood, 1 May 2008, Vol. 111, No. 9, pp. 4446-4455.
Prepublished online as a Blood First Edition Paper on January 31, 2008; DOI 10.1182/blood-2007-08-019729.
 Previous Article | Table of Contents | Next Article 
REVIEW ARTICLE
Telomere maintenance and human bone marrow failure
Rodrigo T. Calado1,*, and
Neal S. Young1,*
1 Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Acquired and congenital aplastic anemias recently have been linked molecularly and pathophysiologically by abnormal telomere maintenance. Telomeres are repeated nucleotide sequences that cap the ends of chromosomes and protect them from damage. Telomeres are eroded with cell division, but in hematopoietic stem cells, maintenance of their length is mediated by telomerase. Accelerated telomere shortening is virtually universal in dyskeratosis congenita, caused by mutations in genes encoding components of telomerase or telomere-binding protein (TERT, TERC, DKC1, NOP10, or TINF2). About one-third of patients with acquired aplastic anemia also have short telomeres, which in some cases associate with TERT or TERC mutations. These mutations cause low telomerase activity, accelerated telomere shortening, and diminished proliferative capacity of hematopoietic progenitors. As in other genetic diseases, additional environmental, genetic, and epigenetic modifiers must contribute to telomere erosion and ultimately to disease phenotype. Short telomeres also may cause genomic instability and malignant progression in these marrow failure syndromes. Identification of short telomeres has potential clinical implications: it may be useful in dyskeratosis congenita diagnosis, in suggesting mutations in patients with acquired aplastic anemia, and for selection of suitable hematopoietic stem cell family donors for transplantation in telomerase-deficient patients.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. F. Kendellen, K. S. Barrientos, and C. M. Counter
POT1 Association with TRF2 Regulates Telomere Length
Mol. Cell. Biol.,
October 15, 2009;
29(20):
5611 - 5619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Haneline
TERTrific hormones promote hematopoiesis
Blood,
September 10, 2009;
114(11):
2207 - 2208.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T. Calado, W. T. Yewdell, K. L. Wilkerson, J. A. Regal, S. Kajigaya, C. A. Stratakis, and N. S. Young
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells
Blood,
September 10, 2009;
114(11):
2236 - 2243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Mollica, I. Fleury, C. Belisle, S. Provost, D.-C. Roy, and L. Busque
No Association Between Telomere Length and Blood Cell Counts in Elderly Individuals
J Gerontol A Biol Sci Med Sci,
September 1, 2009;
64A(9):
965 - 967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Kim, F. M. Barlaskar, J. H. Heaton, T. Else, V. R. Kelly, K. T. Krill, J. O. Scheys, D. P. Simon, A. Trovato, W.-H. Yang, et al.
In Search of Adrenocortical Stem and Progenitor Cells
Endocr. Rev.,
May 1, 2009;
30(3):
241 - 263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Chakraborty, C.-L. Sun, L. Francisco, M. Sabado, L. Li, K. L. Chang, S. Forman, S. Bhatia, and R. Bhatia
Accelerated Telomere Shortening Precedes Development of Therapy-Related Myelodysplasia or Acute Myelogenous Leukemia After Autologous Transplantation for Lymphoma
J. Clin. Oncol.,
February 10, 2009;
27(5):
791 - 798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T. Calado, J. A. Regal, M. Hills, W. T. Yewdell, L. F. Dalmazzo, M. A. Zago, P. M. Lansdorp, D. Hogge, S. J. Chanock, E. H. Estey, et al.
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
PNAS,
January 27, 2009;
106(4):
1187 - 1192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
